Trade RANI stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Rani Therapeutics Holdings, Inc. Class A (RANI) is trading at US$0.84, down 0.81% today as of Sep 14, 16:00 EDT. The company has a market capitalisation of US$101.57M. Over the past 52 weeks, RANI has traded between US$0.45 and US$3.87. On Syfe you can trade RANI with $0 commission and add it to your watchlist.
| Previous close | US$0.84 |
|---|---|
| Market cap | US$101.57M |
| 52-week range | US$0.45 – US$3.87 |
| Volume | 371.57K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Rani Therapeutics Holdings, Inc. Class A
Rani Therapeutics Holdings, Inc. engages in the operation of a clinical stage bio-therapeutics company. The company was founded by Mir Imran on February 21, 2012 and is headquartered in San Jose, CA.
Year: 2021
Rani Therapeutics Reports Positive Initial Phase 1a Data for RT-114 in Obesity
Jul 15, 1:27 PM · MT Newswires
Rani Therapeutics, PegBio Collaborate on Oral Delivery of Obesity Drugs
Jul 9, 9:00 PM · MT Newswires
Rani Therapeutics Names Nicholas Maestas CFO
Jun 29, 12:55 PM · MT Newswires
Rani Therapeutics Prices Registered Direct Offering of 12.5 Million Shares
May 26, 2:12 PM · MT Newswires
Rani Therapeutics Holdings, Inc. Class A (RANI) stock is trading at US$0.84, -0.81% from the previous close of US$0.84.
The market cap for Rani Therapeutics Holdings, Inc. Class A (RANI) stock is approximately US$101.57M.
The 52-week high for Rani Therapeutics Holdings, Inc. Class A (RANI) stock is US$3.87.
The 52-week low for Rani Therapeutics Holdings, Inc. Class A (RANI) stock is US$0.45.
Rani Therapeutics Holdings, Inc. Class A (RANI) does not currently pay a dividend.
Stay on top of RANI
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
